Medications for Thromboembolism

3 results

  • dabigatran etexilate

    (Dabigatran Etexilate)
    Mylan Pharmaceuticals Inc.
    Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating and preventing deep vein thrombosis and pulmonary embolism in adults and pediatric patients aged 8-17, and preventing recurrence of venous thromboembolic events.

  • dabigatran etexilate

    (Dabigatran etexilate)
    Dr. Reddy's Laboratories Inc.
    Dabigatran etexilate capsules are indicated for reducing stroke risk in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, providing prophylaxis following hip replacement surgery, and treating and preventing venous thromboembolic events in pediatric patients aged 8 to under 18 years.

  • dipyridamole

    (DIPYRIDAMOLE)
    Amneal Pharmaceuticals of New York LLC
    Dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants for preventing postoperative thromboembolic complications following cardiac valve replacement.